During the past decade, Hematology Oncology Consultants-Clarkston conducted 117 clinical trials. In the 10-year time frame, 117 clinical trials started and 31 clinical trials were completed, i.e. on average, 26.5% percent of trials that started reached the finish line to date. In the past 5 years, 51 clinical trials started and 31 clinical trials were completed. i.e. 60.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hematology Oncology Consultants-Clarkston" #1 sponsor was "National Cancer Institute (NCI)" with 61 trials, followed by "Alliance for Clinical Trials in Oncology" with 27 trials sponsored, "SWOG Cancer Research Network" with 21 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 12 trials sponsored and "NRG Oncology" with 12 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hematology Oncology Consultants-Clarkston" #1 collaborator was "National Cancer Institute (NCI)" with 71 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator and "Millennium Pharmaceuticals, Inc." with 2 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Hematology Oncology Consultants-Clarkston" are "Stage IV Lung Cancer AJCC v8" (9 trials), "Recurrent Lung Non-Small Cell Carcinoma" (6 trials), "Stage IVA Lung Cancer AJCC v8" (6 trials), "Stage IVB Lung Cancer AJCC v8" (6 trials) and "Invasive Breast Carcinoma" (5 trials). Many other conditions were trialed in "Hematology Oncology Consultants-Clarkston" in a lesser frequency.

Most popular intervention types in "Hematology Oncology Consultants-Clarkston" are "Drug" (106 trials), "Other" (78 trials), "Biological" (51 trials), "Procedure" (37 trials) and "Radiation" (9 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (39 trials), "Laboratory Biomarker Analysis" (29 trials), "Questionnaire Administration" (26 trials), "Biospecimen Collection" (23 trials) and "Computed Tomography" (23 trials). Other intervention names were less common.

The vast majority of trials in "Hematology Oncology Consultants-Clarkston" are 115 trials for "All" genders, 16 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hematology Oncology Consultants-Clarkston". undefined are not yet recruiting, 50 are recruiting, 61 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Hematology Oncology Consultants-Clarkston, 4 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Hematology Oncology Consultants-Clarkston, 2 "Phase 1" clinical trials were conducted, 67 "Phase 2" clinical trials and 66 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".